m+Medelevator.RU
← Поиск публикаций
The Journal of biological chemistry · 2026

Attenuated lamin A-prohibitin2 interaction leads to mitochondrial dysfunction in LMNA 289 A>G-mediated dilated cardiomyopathy.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Nath Subhradip, Prusty Debasish, Islam Sk Ramiz, Manna Soumen Kanti, Sengupta Kaushik

Аннотация

Lamins are critical in maintaining nuclear homeostasis, chromosome positioning, and modulating mechanotransduction. Recent studies indicated the involvement of lamin A in mitochondrial homeostasis and the regulation of superoxide. Missense mutations in LMNA are linked to a spectrum of diseases known as laminopathies, which include conditions, such as dilated cardiomyopathy (DCM), muscular dystrophy, and progeria. K97E is one such mutation, which leads to DCM with severe phenotypes. In this study, we established direct reduction of interaction between lamin A K97E and prohibitin 2. As a sequel, mitochondria exhibited reduced fusion, elevated fragmentation, and ATP deficiency. On the other hand, impaired RhoA/extracellular signal-regulated kinase/focal adhesion kinase signaling cascade disrupted filamentous actin assembly, thereby promoting actin-mitochondria association, further facilitating mitochondrial fission. This feedback loop led to mitochondrial depolarization, and global metabolic derangement, in particular, reduced glycolytic capacity and incomplete fatty acid oxidation accompanied by elevated superoxide levels. In cardiomyocytes, such dysfunction may be correlated with contractile defects and arrhythmias. Thus, our findings elucidated for the first time the pivotal role of lamin A in cellular bioenergetics and mechanotransduction, offering novel insights into DCM pathophysiology, which could open newer vistas for developing targeted therapeutic strategies.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты